Australia markets closed

ABBV Jun 2023 170.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.05000.0000 (0.00%)
As of 01:28PM EDT. Market open.
Full screen
Loading interactive chart…
  • PR Newswire

    AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022

    AbbVie (NYSE: ABBV) today revealed the spectrum of new data from studies of risankizumab (SKYRIZI®) in Crohn's disease and upadacitinib (RINVOQ®) in ulcerative colitis and Crohn's disease that will be presented as live presentations and e-Posters at the United European Gastroenterology (UEG) Week 2022, October 8-11 in Vienna and online. In total, AbbVie is presenting 17 abstracts across a broad range of studies in inflammatory bowel disease (IBD).

  • Simply Wall St.

    AbbVie Inc. (NYSE:ABBV) is a favorite amongst institutional investors who own 70%

    To get a sense of who is truly in control of AbbVie Inc. ( NYSE:ABBV ), it is important to understand the ownership...

  • Motley Fool

    Where to Invest $10,000 Right Now

    Prolonged periods of volatility along with dips near or even into bear market territory have become commonplace for investors in recent months as fears of a looming recession, geopolitical headwinds, and ongoing concerns about the global economy continue to remain front of mind. For investors who have the capital to put to work right now, even a market like the one we're seeing presents its own share of opportunities to invest in these types of compelling companies at a bargain. Healthcare stocks had quite the heyday in the early pandemic, when investors were rushing to put their cash into any and all companies in this space.